Rankin EB, Fuh KC, Taylor TE, Krieg AJ, Musser M, Yuan J, Wei K, Kuo CJ, Longacre TA, Giaccia AJ (2010). AXL is an essential factor and therapeutic target for metastatic ovarian cancer. Cancer Research 70(19):7570-9.
http://cancerres.aacrjournals.org/content/70/19/7570.long